Homepage
Open in app
Sign in
Get started
Lazarus AI
Lazarus is a startup that’s changing the way we screen for and diagnose cancer.
Follow
Jessica Pyhtila
Mar 10
FDA Approves Combination Treatment for BPH Symptoms
Read more…
Jessica Pyhtila
Feb 17
FDA Approves New Orally Disintegrating Dosage Form of Glycopyrrolate
Read more…
1
Jessica Pyhtila
Jan 31
FDA Approves Novel PCSK9 Inhibitor Inclisiran (Leqvio)
Read more…
Manijeh “Mani” Berenji
Jan 5
Evaluating the Effectiveness of Biologic Agents for Metastatic Colon Cancer among Black and White Americans: A Study…
Read more…
Jessica Pyhtila
Dec 28, 2021
FDA Approves Rivaroxaban in an Oral Suspension Dosage Form
Read more…
1
Manijeh “Mani” Berenji
Dec 20, 2021
Adverse Pregnancy Outcomes and Incident Heart Failure in the Women’s Health Initiative: A Review
Read more…
Manijeh “Mani” Berenji
Dec 13, 2021
Risk of Guillain-Barré in Recipients of the Zoster Recombinant Vaccine Shingrix: Review of a Case Series Cohort Study
Read more…
Manijeh “Mani” Berenji
Dec 6, 2021
Osteoarthritis and Use of Non-Steroidal Anti-Inflammatories: The Latest Analysis
Read more…
Jessica Pyhtila
Oct 12, 2021
FDA Approves Atogepant As Newest CGRP Antagonist for Migraine Prevention
Read more…
Jessica Pyhtila
Oct 7, 2021
FDA Approves Ergot-Derivative Nasal Spray to Treat Acute Migraine
Read more…
10
About Lazarus AI
Latest Stories
Archive
About Medium
Terms
Privacy
